Revista fisio&terapia.June 25, 2026Daiane Lima de Lara Ziles, Jigliane Tainã Macedo de Souza, Yoda Janaina Ikenohuchi et al.
The treatment of resistant depression represents a significant challenge in psychiatry, as a considerable portion of patients do not adequately respond to conventional therapies. In this context, new psychedelic drugs have emerged as promising therapeutic alternatives, garnering increasing interest from the scientific and clinical community. The overall objective of this research is to analyze...
Revista fisio&terapia.October 8, 2025Maurício Pedro Luciano da Costa, Pedro Bruschi Peiretti, Pedro Vinicius Rodrigues Silveira Silva et al.
A resurgence of scientific and clinical interest in psychedelic-assisted therapies, particularly with Psilocybin, has been observed. This paper presents an integrative literature review aiming to identify the scientific contributions, potential benefits, and limitations of the therapeutic use of psilocybin in mental health. The study followed a rigorous protocol. Searches were conducted in the...
Depression is a common disorder around the world, according to the WHO (World Health Organization) about 350 million people worldwide suffer from the disease, a number that is growing every day. Brazil is the second country in the Americas with the highest number of depressive people, where about 5.8% of the population has been diagnosed with the pathology. Depression is a chronic and recurrent...
Revista fisio&terapia.August 15, 2024Alberto Almeida, Carlos Paulo da Silva, Clara Guerzoni et al.
This integrative review explores the use of psychedelics in psychiatry, focusing on their historical context, recent resurgence, and clinical efficacy in treating psychiatric disorders such as depression, PTSD, and anxiety. Initially, psychedelic therapies showed promise in the 1950s and 1970s but were diminished due to restrictive policies and stigma. However, a resurgence in clinical interest...